Ipsen SA annual free cash flow
2020
2021
2022
2023
2024
2025
Ipsen SA Free Cash Flow (FCF) History (IPN)
Ipsen SA reported €809.7M in free cash flow for fiscal 2025, an increase of 508.80% from the previous fiscal year, with a free cash flow margin of 20.61%.
View full Ipsen SA company overviewIpsen SA free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | €809.7M | €676.7M | +508.80% | +20.61% |
| 2024 | 2024-12-31 | €133.0M | −€544.0M | −80.35% | +3.72% |
| 2023 | 2023-12-31 | €677.0M | −€41.5M | −5.78% | +20.48% |
| 2022 | 2022-12-31 | €718.5M | −€78.8M | −9.88% | +22.76% |
| 2021 | 2021-12-31 | €797.3M | €107.4M | +15.57% | +26.58% |
| 2020 | 2020-12-31 | €689.9M | — | — | +25.68% |
Ipsen SA free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from €689.9M to €809.7M, a compound annual growth rate of 3.25%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
